IGHS Group and Consult Invest celebrate a contract for Central Asian Countries.

The IGHS signed today, in Tashkent, Uzbekistan, a contract with the multinational Consult Invest, for the representation of services and products of Idealmed GHS and its brand new biothech company, Innov-Cell Therapeutics, for the Central Asian Countries.

This contract includes the design, development and management of hospitals in Uzbekistan and Kazakhstan, as well as the pharmaceutical distribution of Innov-Cell Therapeutics products for all the regions of Central Asia.

For José Alexandre Cunha, Chairman of IGHS Group "the celebration of this contract, which has the strong support of the local governments, demonstrates a great recognition of IGHS work and projects developed in the international market and represents a huge opportunity in a region that has shown a unique growth. Once again, we are able to assume that from Portugal, and in particular from Coimbra, it’s possible to strengthen our skills in a such competitive sector.
 

• OIH Introduces Revolutionary Treatment for Keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS)

  Oman International Hospital is thrilled to announce the successful introduction of a groundbreaking procedure designed to treat keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS). This innovative treatment marks a significant advancement in ophthalmology, offering new hope to patients suffering from this debilitating corneal disorder.
   

  Read more
• IGHS celebrates the inauguration of new Insparya Clinic at Oman International Hospital

  With the presence of the distinguished shareholders, Sheika Amal Suhail Bahwan - representing Suhail Bahwan Group, and Mr. Fathi Al Balushi - representing Oman Brunei Investment Company, Insparya announces its strategic partnership with IGHS, inaugurating its new branch at Oman International Hospital.

  Read more